Back to GetFilings.com





UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 10-Q

(Mark One)

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended March 31, 2004.

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from _______________ to _______________

Commission file number:  0-27718

NEOSE TECHNOLOGIES, INC.


(Exact name of registrant as specified in its charter)

 

Delaware

 

13-3549286


 


(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

102 Witmer Road

 

 

Horsham, Pennsylvania

 

19044


 


(Address of principal executive offices)

 

(Zip Code)

 

 

 

(215) 315-9000


(Registrant’s telephone number, including area code)

          Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      

Yes   x      No    o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes    x     No   o

          Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  19,948.921 shares of common stock, $.01 par value, were outstanding as of April 20, 2004.



NEOSE TECHNOLOGIES, INC.
(a development-stage company)

INDEX

 

 

Page

 

 


 

 

 

PART I.

FINANCIAL INFORMATION:

 

 

 

 

     Item 1.

Financial Statements (unaudited)

 

 

 

 

 

Balance Sheets as of December 31, 2003 and March 31, 2004

3

 

 

 

 

Statements of Operations for the three months ended March 31, 2003 and 2004, and for the period from inception through March 31, 2004

4

 

 

 

 

Statements of Cash Flows for the three months ended March 31, 2003 and 2004, and for the period from inception through March 31, 2004

5

 

 

 

 

Notes to Financial Statements

6

 

 

 

     Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

10

 

 

 

     Item 3.

Quantitative and Qualitative Disclosure About Market Risk

20

 

 

 

     Item 4.

Controls and Procedures

21

 

 

 

PART II.

OTHER INFORMATION:

 

 

 

 

     Item 6.

Exhibits and Reports on Form 8-K

21

 

 

 

SIGNATURES

 

23

2



PART I.     FINANCIAL INFORMATION

Item 1.        Financial Statements

NEOSE TECHNOLOGIES, INC.
(a development-stage company)

BALANCE SHEETS
(unaudited)
(in thousands, except per share amounts)

 

 

December 31, 2003

 

March 31, 2004

 

 

 


 


 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

     Cash and cash equivalents

 

 

$

48,101

 

 

 

$

39,917

 

 

     Marketable securities

 

 

 

4,959

 

 

 

 

4,974

 

 

     Restricted funds

 

 

 

901

 

 

 

 

-

 

 

     Prepaid expenses and other current assets

 

 

 

917

 

 

 

 

1,906

 

 

 

 

 



 

 

 



 

 

          Total current assets

 

 

 

54,878

 

 

 

 

46,797

 

 

Property and equipment, net

 

 

 

37,192

 

 

 

 

40,691

 

 

Acquired intellectual property, net

 

 

 

1,910

 

 

 

 

1,760

 

 

Other assets

 

 

 

865

 

 

 

 

845

 

 

 

 

 



 

 

 



 

 

Total assets

 

 

$

94,845

 

 

 

$

90,093

 

 

 

 

 



 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

     Current portion of long-term debt and capital lease obligations

 

 

$

2,231

 

 

 

$

2,756

 

 

     Accounts payable

 

 

 

2,342

 

 

 

 

1,835

 

 

     Accrued compensation

 

 

 

2,510

 

 

 

 

1,218

 

 

     Accrued expenses

 

 

 

2,433

 

 

 

 

2,780

 

 

     Deferred revenue

 

 

 

4,333

 

 

 

 

4,789

 

 

 

 

 



 

 

 



 

 

          Total current liabilities

 

 

 

13,849

 

 

 

 

13,378

 

 

Long-term debt and capital lease obligations

 

 

 

8,370

 

 

 

 

13,544

 

 

Other liabilities

 

 

 

413

 

 

 

 

331

 

 

 

 

 



 

 

 



 

 

          Total liabilities

 

 

 

22,632

 

 

 

 

27,253

 

 

 

 

 



 

 

 



 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

     Preferred stock, $.01 par value, 5,000 shares
          authorized, none issued

 

 

 

-

 

 

 

 

-

 

 

     Common stock, $.01 par value, 30,000 shares
          authorized; 19,935 and 19,949 shares issued and outstanding

 

 

 

199

 

 

 

 

199

 

 

     Additional paid-in capital

 

 

 

217,849

 

 

 

 

217,966

 

 

     Deferred compensation

 

 

 

(96

)

 

 

 

(83

)

 

     Deficit accumulated during the development-stage

 

 

 

(145,739

)

 

 

 

(155,242

)

 

 

 

 



 

 

 



 

 

          Total stockholders’ equity

 

 

 

72,213

 

 

 

 

62,840

 

 

 

 

 



 

 

 



 

 

Total liabilities and stockholders’ equity

 

 

$

94,845

 

 

 

$

90,093

 

 

 

 

 



 

 

 



 

 

The accompanying notes are an integral part of these financial statements.

3



NEOSE TECHNOLOGIES, INC.
(a development-stage company)

STATEMENTS OF OPERATIONS
(unaudited)
(in thousands, except per share amounts)

 

 

Three months

 

Period from

 

 

 

ended March 31,

 

inception

 

 

 


 

(January 17, 1989)

 

 

 

2003

 

2004

 

to March 31, 2004

 

 

 


 


 


 

 

 

 

 

 

 

 

 

Revenue from collaborative agreements

 

$

70

 

$

1,250

 

 

$

20,131

 

 

 

 



 



 

 



 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

     Research and development

 

 

5,619

 

 

7,878

 

 

 

134,377

 

 

     Marketing, general and administrative

 

 

3,005

 

 

2,862

 

 

 

63,082

 

 

 

 



 



 

 



 

 

          Total operating expenses

 

 

8,624

 

 

10,740

 

 

 

197,459

 

 

 

 



 



 

 



 

 

Operating loss

 

 

(8,554

)

 

(9,490

)

 

 

(177,328

)

 

Other income

 

 

-

 

 

-

 

 

 

7,773

 

 

Impairment of equity securties

 

 

-

 

 

-

 

 

 

(1,250

)

 

Interest income

 

 

170

 

 

105

 

 

 

19,447

 

 

Interest expense

 

 

(37

)

 

(118

)

 

 

(3,884

)

 

 

 



 



 

 



 

 

Net loss

 

$

(8,421

)

$

(9,503

)

 

$

(155,242

)

 

 

 



 



 

 



 

 

Basic and diluted net loss per share

 

$

(0.53

)

$

(0.48

)

 

 

 

 

 

 

 



 



 

 

 

 

 

 

Weighted-average shares outstanding used in
     computing basic and diluted net loss per share

 

 

15,801

 

 

19,943

 

 

 

 

 

 

 

 



 



 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

4



NEOSE TECHNOLOGIES, INC.
(a development-stage company)
STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)

 

 

Three months ended

 

Period from

 

 

 

March 31,

 

inception

 

 

 


 

(January 17, 1989)

 

 

 

2003

 

2004

 

to March 31, 2004

 

 

 


 


 


 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

     Net loss

 

$

(8,421

)

$

(9,503

)

 

$

(155,242

)

 

     Adjustments to reconcile net loss to cash used in
          operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

          Depreciation and amortization

 

 

1,048

 

 

1,347

 

 

 

19,274

 

 

          Loss on disposition of property and equipment

 

 

 

 

 

-

 

 

 

264

 

 

          Non-cash compensation

 

 

-

 

 

14

 

 

 

4,931

 

 

          Common stock issued for non-cash and other charges

 

 

-

 

 

-

 

 

 

35

 

 

          Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

               Prepaid expenses and other current and non-current assets

 

 

(888

)

 

(1,083

)

 

 

(2,314

)

 

               Accounts payable

 

 

(256

)

 

(507

)

 

 

1,835

 

 

               Accrued compensation

 

 

(612

)

 

(1,292

)

 

 

799

 

 

               Accrued expenses

 

 

(249

)

 

(98

)

 

 

1,480

 

 

               Deferred revenue

 

 

-

 

 

456

 

 

 

4,789

 

 

               Other liabilities

 

 

2

 

 

(82

)

 

 

(88

)

 

 

 



 



 

 



 

 

                    Net cash used in operating activities

 

 

(9,376

)

 

(10,748

)

 

 

(124,237

)

 

 

 



 



 

 



 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

     Purchases of property and equipment

 

 

(353

)

 

(3,968

)

 

 

(54,531

)

 

     Proceeds from sale-leaseback of equipment

 

 

-

 

 

-

 

 

 

1,382

 

 

     Purchases of marketable securities

 

 

(18,259

)

 

-

 

 

 

(423,307

)

 

     Proceeds from sales of marketable securities

 

 

-

 

 

-

 

 

 

29,686

 

 

     Proceeds from maturities of and other changes in marketable
          securities

 

 

10,000